ציין מניה או מטבע קריפטוגרפי בשורת החיפוש כדי לקבל סיכום
Immunoprecise Antibodies Ltd
IPAImmunoPrecise Antibodies Ltd. operates as a biotherapeutic research and technology company in Canada, the United States, Europe, Canada, Australia, and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. In addition, it provides phage display, a custom immune library from multiple species; CAR development, an adaptable antibody, which allows the inclusion of functional data early in the screening funnel; antibody sequencing; and assay development. Further, the company offers silico developability, a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of critical quality attributes. Additionally, it provides LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; antibody chimerization for cloning and production of variable antibody domain; Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom applications; breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts; and protein manufacturing services. The company is headquartered in Victoria, Canada. Address: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8
Analytics
מחיר יעד של וול סטריט
5.99 USDיחס רווח למחיר
–תשואת דיבידנד
–השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
דמויות מפתח IPA
ניתוח דיבידנדים IPA
גידול דיבידנד במשך 5 שנים
–צמיחה מתמשכת
–יחס תשלום ממוצע של 5 שנים
–היסטוריית דיבידנדים IPA
שווי מניות IPA
פיננסיים IPA
תוצאות | 2019 | דינמיקה |